Role of chromatin remodeling protein ARID1A in MLL-AF9 leukemogenesis
Evidence identifying ARID1A as a vital driver and therapeutic target in AML
INDICATION
Acute Myeloid Leukemia
BIOMARKER
ARID1A
Related cases
Evidence identifying ARID1A as a vital driver and therapeutic target in AML
Related cases